No Link Between Cell Phones and Cancer in Scandinavian Study

December 7, 2009 — Brain tumor rates in four Scandinavian countries have not increased since use of cell phones became widespread in the 1990s. These results were published in the Journal of the National Cancer Institute.

FDA Approves Votrient™ for Kidney Cancer

December 7, 2009 — On October 29, 2009 the FDA approved Votrient™ (pazopanib) for the treatment of advanced renal cell carcinoma (kidney cancer).

Home Care Nursing Improves Symptom Management

December 7, 2009 — Researchers from the UK have reported that symptom management for patients with breast and colorectal cancer treated with oral Xeloda® (capecitabine) was better for patients who received home care nursing than for patients receiving standard care. The results of this study appeared in an early online publication in the Journal of Clinical Oncology on November 16, 2009.

Cervarix® Vaccination Against HPV Lasts at Least Six Years

December 7, 2009 — Researchers affiliated with the GlaxoSmithKline Vaccine HPV-007 Study Group have reported that Cervarix® [human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine] has “high and sustained immunogenicity, and a favorable safety” profile for up to 6.4 years following administration. The details of this study appeared in an early online publication in the Lancet on December 3, 2009.

Group to start project to cut indoor fuel burning

December 7, 2009 — CANCUN, Mexico (Reuters) - An advocacy group on lung health plans to work with health authorities in 12 countries from 2010 to reduce indoor fuel burning, which causes respiratory diseases and lung cancer and kills 2 million people a year.